{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T04:42:56Z","timestamp":1792816976030,"version":"4.5.0"},"reference-count":30,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2021,9,21]],"date-time":"2021-09-21T00:00:00Z","timestamp":1632182400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["TropicalMed"],"abstract":"<jats:p>Reactivation of latent tuberculosis infection (LTBI) or latent parasitic infection (LPI) during drug-induced immunosuppression can have serious consequences. The Division of tropical and humanitarian medicine of the Geneva University Hospitals runs a specific consultation for parasitic screening of immunosuppressed or pre-immunosuppressed patients. We sought to determine the seroprevalence of LTBI and LPI in such patients and explore its relationship with country of origin or previous travel in a retrospective, single-centre observational study from 2016 to 2019. Demographic data, travel history, ongoing treatments and results of the parasitological (Strongyloides stercoralis, Trypanosoma cruzi, Echinococcus multilocularis, Entamoeba histolytica and Leishmania spp.) and TB screening were collected to calculate LPI or LTBI prevalence. Risk factors for LTBI and strongyloidiasis were analysed using Poisson regression with robust variance. Among 406 eligible patients, 24\/353 (6.8%) had LTBI, 8\/368 (2.2%) were positive for Strongyloides stercoralis infection, 1\/32 (3.1%) was positive for Entamoeba histolytica and 1\/299 (0.3%) was positive for Leishmaniasis. No cases of Trypanosoma cruzi (0\/274) or Echinococcus multilocularis (0\/56) infection were detected. Previous travel to or originating from high-prevalence countries was a risk factor for LTBI (PR = 3.4, CI 95%: 1.4\u20138.2 and 4.0, CI 95%: 1.8\u20138.9, respectively). The prevalence of serological Strongyloidiasis in immunosuppressed patients is lower in comparison to those without immunosuppression (PR = 0.1, CI 95%: 0.01\u20130.8). In conclusion, screening before immunosuppression needs to be individualized, and LTBI and LPI need to be ruled out in patients who originate from or have travelled to high-prevalence countries. The sensitivity of strongyloidiasis serology is reduced following immunosuppression, so an algorithm combining different tests or presumptive treatment should be considered.<\/jats:p>","DOI":"10.3390\/tropicalmed6030170","type":"journal-article","created":{"date-parts":[[2021,9,21]],"date-time":"2021-09-21T22:35:20Z","timestamp":1632263720000},"page":"170","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Screening for Parasitic Infection and Tuberculosis in Immunosuppressed and Pre-Immunosuppressed Patients: An Observational Study"],"prefix":"10.3390","volume":"6","author":[{"given":"Luisa","family":"Carnino","sequence":"first","affiliation":[{"name":"Division of Tropical and Humanitarian Medicine, Geneva University Hospitals, Rue Gabrielle-Perret-Gentil 6, 1205 Geneva, Switzerland"},{"name":"Faculty of Medicine, University of Geneva, Rue Michel-Servet 1, 1205 Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2071-1005","authenticated-orcid":false,"given":"Jean-Marc","family":"Schwob","sequence":"additional","affiliation":[{"name":"Division of Tropical and Humanitarian Medicine, Geneva University Hospitals, Rue Gabrielle-Perret-Gentil 6, 1205 Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6970-2869","authenticated-orcid":false,"given":"Dionysios","family":"Neofytos","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Geneva University Hospitals, Rue Gabrielle-Perret-Gentil 6, 1205 Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Lazo-Porras","sequence":"additional","affiliation":[{"name":"Division of Tropical and Humanitarian Medicine, Geneva University Hospitals, Rue Gabrielle-Perret-Gentil 6, 1205 Geneva, Switzerland"},{"name":"CRONICAS Center of Excellence in Chronic Diseases, Universidad Peruana Cayetano Heredia, Lima 15102, Peru"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Chappuis","sequence":"additional","affiliation":[{"name":"Division of Tropical and Humanitarian Medicine, Geneva University Hospitals, Rue Gabrielle-Perret-Gentil 6, 1205 Geneva, Switzerland"},{"name":"Faculty of Medicine, University of Geneva, Rue Michel-Servet 1, 1205 Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles","family":"Eperon","sequence":"additional","affiliation":[{"name":"Division of Tropical and Humanitarian Medicine, Geneva University Hospitals, Rue Gabrielle-Perret-Gentil 6, 1205 Geneva, Switzerland"},{"name":"Faculty of Medicine, University of Geneva, Rue Michel-Servet 1, 1205 Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,9,21]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"e214920","DOI":"10.1001\/jamanetworkopen.2021.4920","article-title":"Prevalence of Immunosuppressive Drug Use Among Commercially Insured US Adults, 2018\u20132019","volume":"4","author":"Wallace","year":"2021","journal-title":"JAMA Netw. Open"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.3201\/eid2608.191493","article-title":"Analysis of MarketScan Data for Immunosuppressive Conditions and Hospitalizations for Acute Respiratory Illness, United States","volume":"26","author":"Patel","year":"2020","journal-title":"Emerg. Infect. Dis."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.4269\/ajtmh.16-0458","article-title":"Imported Disease Screening Prior to Chemotherapy and Bone Marrow Transplantation for Oncohematological Malignancies","volume":"95","author":"Camps","year":"2016","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_4","unstructured":"(2021, July 27). Statistiques Cantonal Etat de Geneve, Available online: https:\/\/www.ge.ch\/statistique\/domaines\/apercu.asp."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Jackson, Y., Paignon, A., Wolff, H., and Delicado, N. (2018). Health of undocumented migrants in primary care in Switzerland. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0201313"},{"key":"ref_6","unstructured":"Longchamp, C., Aebersold, M., Rousselot, B., and Ratelband-Pally, S. (2005). Sans Papier in der Schweiz: Arbeitsmarkt, nicht Asylpolitik ist entscheidend, Gfs."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Davis, J.S., Ferreira, D., Paige, E., Gedye, C., and Boyle, M. (2020). Infectious Complications of Biological and Small Molecule Targeted Immunomodulatory Therapies. Clin. Microbiol. Rev., 33.","DOI":"10.1128\/CMR.00035-19"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s40257-015-0124-x","article-title":"Screening and Vaccinations in Patients Requiring Systemic Immunosuppression: An Update for Dermatologists","volume":"16","author":"Goyal","year":"2015","journal-title":"Am. J. Clin. Dermatol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1111\/ajt.12666","article-title":"Considerations for Screening Live Kidney Donors for Endemic Infections: A Viewpoint on the UNOS Policy: Live Kidney Donor Screening for Endemic Infections","volume":"14","author":"Levi","year":"2014","journal-title":"Am. J. Transplant."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"645","DOI":"10.4269\/ajtmh.16-0923","article-title":"Evidence-Based Guidelines for Screening and Management of Strongyloidiasis in Non-Endemic Countries","volume":"97","author":"Bisoffi","year":"2017","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_11","first-page":"922","article-title":"The immunosuppressed traveler: Vaccination guidelines","volume":"14","author":"Eperon","year":"2018","journal-title":"Rev. Med. Suisse"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.3201\/eid1012.030773","article-title":"Risk factors for alveolar echinococcosis in humans","volume":"10","author":"Kern","year":"2004","journal-title":"Emerg. Infect. Dis."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s10238-012-0192-7","article-title":"Negative effect of immunosuppressive therapy in the performance of the QuantiFERON Gold In-Tube test in patients with immune-mediated inflammatory diseases","volume":"13","author":"Ramos","year":"2012","journal-title":"Clin. Exp. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1900655","DOI":"10.1183\/13993003.00655-2019","article-title":"The global prevalence of latent tuberculosis: A systematic review and meta-analysis","volume":"54","author":"Cohen","year":"2019","journal-title":"Eur. Respir. J."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Houben, R.M.G.J., and Dodd, P.J. (2016). The Global Burden of Latent Tuberculosis Infection: A Re-estimation Using Mathematical Modelling. PLoS Med., 13.","DOI":"10.1371\/journal.pmed.1002152"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"e022445","DOI":"10.1136\/bmjopen-2018-022445","article-title":"Screening and prevention for latent tuberculosis in immunosuppressed patients at risk for tuberculosis: A systematic review of clinical practice guidelines","volume":"8","author":"Hasan","year":"2018","journal-title":"BMJ Open"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Chadwick, D.R., Sayeed, L., Rose, M., Budd, E., Mohammed, M., Harrison, S., Azad, J., and Maddox, J. (2020). Adherence to guidelines across different specialties to prevent infections in patients undergoing immunosuppressive therapies. BMC Infect. Dis., 20.","DOI":"10.1186\/s12879-020-05082-8"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"e13406","DOI":"10.1111\/ijcp.13406","article-title":"Infectious disease screening in patients prior to undergoing immunosuppressive therapy","volume":"73","author":"Sullivan","year":"2019","journal-title":"Int. J. Clin. Pract."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"15406","DOI":"10.1038\/s41598-018-33775-3","article-title":"Prevalence of Strongyloides stercoralis infection and hyperinfection syndrome among renal allograft recipients in Central Europe","volume":"8","author":"Winnicki","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"401","DOI":"10.4269\/ajtmh.16-0068","article-title":"Comparative Diagnosis of Strongyloidiasis in Immunocompromised Patients","volume":"95","author":"Luvira","year":"2016","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_21","unstructured":"(2021, July 03). Presumptive Treatment and Screening for Strongyloidiasis, Infections Caused by Other Soil-Transmitted Helminths, and Schistosomiasis Among Newly Arrived Refugees, Available online: https:\/\/www.cdc.gov\/immigrantrefugeehealth\/guidelines\/domestic\/intestinal-parasites-domestic.html."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1001\/jama.2020.13170","article-title":"COVID-19 and Dexamethasone: A Potential Strategy to Avoid Steroid-Related Strogyloides Hyperinfection","volume":"324","author":"Stauffer","year":"2020","journal-title":"JAMA"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Akuffo, H., Costa, C., Van Griensven, J., Burza, S., Moreno, J., and Herrero, M. (2018). New insights into leishmaniasis in the immunosuppressed. PLoS Negl. Trop. Dis., 12.","DOI":"10.1371\/journal.pntd.0006375"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.3201\/eid1407.071589","article-title":"Spread of Vector-borne Diseases and Neglect of Leishmaniasis, Europe","volume":"14","author":"Dujardin","year":"2008","journal-title":"Emerg. Infect. Dis."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"19963","DOI":"10.2807\/ese.16.37.19963-en","article-title":"Chagas disease in Switzerland: History and challenges","volume":"16","author":"Jackson","year":"2011","journal-title":"Eurosurveillance"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Moreira, M.d.C.V., and Cunha-Melo, R.J. (2020). Chagas Disease Infection Reactivation after Heart Transplant. Trop. Med., 5.","DOI":"10.3390\/tropicalmed5030106"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"878","DOI":"10.3201\/eid1306.061074","article-title":"Human Alveolar Echinococcosis after Fox Population Increase, Switzerland","volume":"13","author":"Schweiger","year":"2007","journal-title":"Emerg. Infect. Dis."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1093\/cid\/ciu520","article-title":"Increased Incidence and Characteristics of Alveolar Echinococcosis in Patients With Immunosuppression-Associated Conditions","volume":"59","author":"Chauchet","year":"2014","journal-title":"Clin. Infect. Dis."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1051\/parasite\/2014037","article-title":"Comparison of the serological tests ICT and ELISA for the diagnosis of alveolar echinococcosis in France","volume":"21","author":"Knapp","year":"2014","journal-title":"Parasite"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.neurol.2015.10.006","article-title":"Epidemiology of multiple sclerosis","volume":"172","author":"Leray","year":"2016","journal-title":"Rev. Neurol. Paris"}],"container-title":["Tropical Medicine and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2414-6366\/6\/3\/170\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:02:55Z","timestamp":1760166175000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2414-6366\/6\/3\/170"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,21]]},"references-count":30,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2021,9]]}},"alternative-id":["tropicalmed6030170"],"URL":"https:\/\/doi.org\/10.3390\/tropicalmed6030170","relation":{},"ISSN":["2414-6366"],"issn-type":[{"value":"2414-6366","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,21]]}}}